Showing results (1-10 of 239) with videos related to
Sort By:
Pageof 24
Med (New York, N.Y.)|May 19, 2022
A powerful tool to study metabolic reprogramming in pediatric cancersRindert Missiaen, M Celeste SimonThe EMBO Journal|February 22, 2023
HIF: a master regulator of nutrient availability and metabolic cross-talk in the tumor microenvironmentRindert Missiaen, Nicholas P Lesner, M Celeste SimonMolecular Cancer Research : MCR|January 12, 2021
Cell-Intrinsic Tumorigenic Functions of PPARγ in Bladder Urothelial CarcinomaDanielle J Sanchez, Rindert Missiaen, Nicolas Skuli, et al.Seminars in Cancer Biology|June 24, 2018
The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancerRindert Missiaen, Massimiliano Mazzone, Gabriele BergersCold Spring Harbor Symposia on Quantitative Biology|April 12, 2017
Trimming the Vascular Tree in Tumors: Metabolic and Immune AdaptationsElizabeth Allen, Rindert Missiaen, Gabriele BergersVascular Pharmacology|January 14, 2017
Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspectiveRindert Missiaen, Francisco Morales-Rodriguez, Guy Eelen, et al.Cell Metabolism|July 15, 2022
GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatmentRindert Missiaen, Nicole M Anderson, Laura C Kim, et al.Cancer Research|July 8, 2021
Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk NeuroblastomaNicole M Anderson, Xiaodan Qin, Jennifer M Finan, et al.Advances in Experimental Medicine and Biology|November 9, 2006
Mitochondrial reactive oxygen species are required for hypoxic HIF alpha stabilizationM Celeste SimonCell Metabolism|March 7, 2006
Coming up for air: HIF-1 and mitochondrial oxygen consumptionM Celeste SimonPageof 24